Eli Lilly and Co. employees knew the Alzheimer's treatment solanezumab was not a sure bet. But that didn’t make the pain any less acute after the company announced the drug had failed to demonstrate effectiveness during a 2,100-patient Phase 3 clinical trial.
Anthem Inc.’s proposed merger with Cigna Corp. would reduce health-care competition and raise costs for consumers, U.S. antitrust lawyers will argue Monday when the government goes to court to try to block the transaction.
Cryogenic Solutions Inc. is consolidating a recently acquired New York company into Indianapolis and doubling space at its S. Lynhurst Drive headquarters to accommodate it.
Dow Agrosciences parent Dow Chemical Co. and DuPont Co. face further delays to their plans to create the world’s biggest chemical company
Indianapolis-based Dow AgroSciences said sales and operating earnings rose in the third quarter, thanks in part to strong demand for products in Latin America. Meanwhile, the massive merger between parent Dow Chemical and DuPont has been delayed.
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
The Indianapolis drugmaker's animal-health division is bulking up its companion-animal business by buying Boehringer Ingelheim International's U.S. feline, canine and rabies medications.
Rainer Fischer most recently served as senior executive director of the Fraunhofer Institute for Molecular Biology and Applied Ecology in Germany. The institute is part of the largest applied science research organization in Europe.
In a Q&A, Monon Bioventures CEO Joe Trebley talks about the goals and ambitions of his one-year-old firm.
Verdure Sciences has filed plans with Noblesville to build a 15,000-square-foot facility on a 7-acre property in the Metro Enterprise Park near the southwest corner of Pleasant Street and Union Chapel Road.
Bayer AG has agreed to buy Monsanto Co. in a deal valued at $66 billion, winding up four months of talks to create the world’s biggest supplier of seeds and pesticides.
European antitrust officials decided this month to launch a full-blown investigation into the proposed merger Dow Chemical Co. and DuPont Co.
The State Budget Committee has given its approval for Purdue University to build a high-tech, greenhouse-like facility where scientists will map plant genomes.
The West Lafayette-based company has named CFO and COO Mike Sherman as new CEO and president, but did not give a reason for the abrupt change in leadership.
Animated Dynamics Inc. has raised $1.7 million in early funding to help it get its technology to market.
Indiana-based Zimmer Biomet Holdings Inc. has agreed to buy LDR Holding Corp. for about $1 billion in cash to add surgical technologies for the treatment of patients with spine disorders.
Indiana inventors secured 30 percent more patents in 2015 than they did four years earlier.
And at more than 2,000, last year’s number is double the patents granted to Hoosiers in 2008, a low point for patents in the past two decades.
The news is the latest example of a huge shakeup in the agricultural industry.
While many college graduates are leaving the state, jobs in health care and life sciences in Indiana are booming, and employers are often searching high and low for talent.
IBJ gathered leaders in the life sciences industry for a Power Breakfast panel discussion April 21. Panel members included Colleen Hittle, managing director of Navigant; Suresh Garimella, Purdue University’s executive vice president of research and partnerships; Brian Barker, general manager of U.S. Seeds for Dow AgroSciences; Kristin Sherman, former chief financial officer of Calibrium LLC; and David Johnson, CEO of BioCrossroads.
